Life Science REIT PLC Cash Flow
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
2023
2022
2021
11M
-22M
0M
0M
34M
-1M
-12M
24M
-27M
14M
-66.67 %
0M
0M
-15M
14M
-31M
46M
-13M
-1M
-27M
0M
0M
31M
-5M
-186M
8M
67M
4M
-12.5 %
1M
0M
97M
46M
-120M
166M
-1M
4M
8M
0M
0M
-8M
4M
-182M
8M
344M
0M
0 %
0M
0M
-6M
166M
166M
0M
4M
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
4Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
7M
-27M
0M
0M
35M
-1M
0M
15M
-4M
4M
-12.5 %
0M
0M
-8M
14M
-5M
19M
-9M
2M
3M
0M
0M
-1M
0M
0M
4M
-13M
5M
200 %
0M
-5M
-2M
19M
-13M
46M
-5M
2M
3M
0M
0M
0M
0M
0M
4M
-13M
5M
0 %
0M
-5M
-2M
46M
-13M
46M
0M
2M
-17M
0M
0M
39M
-1M
0M
4M
-13M
5M
-40 %
0M
-5M
-2M
46M
-13M
59M
-4M
2M
0M
0M
0M
0M
0M
0M
4M
-13M
5M
0 %
0M
-5M
-2M
59M
-13M
0M
0M
-2M
3M
0M
0M
0M
0M
0M
0M
31M
0M
0 %
0M
32M
-1M
0M
-54M
0M
0M
-2M
3M
0M
0M
0M
0M
0M
0M
31M
0M
0 %
0M
32M
-1M
0M
-54M
0M
0M